ES2108066T3 - Nuevas ftalazinas que en posicion 1 contienen una agrupacion eter, y procedimiento para su preparacion. - Google Patents

Nuevas ftalazinas que en posicion 1 contienen una agrupacion eter, y procedimiento para su preparacion.

Info

Publication number
ES2108066T3
ES2108066T3 ES92117672T ES92117672T ES2108066T3 ES 2108066 T3 ES2108066 T3 ES 2108066T3 ES 92117672 T ES92117672 T ES 92117672T ES 92117672 T ES92117672 T ES 92117672T ES 2108066 T3 ES2108066 T3 ES 2108066T3
Authority
ES
Spain
Prior art keywords
rest
phthalazines
eter
grouping
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92117672T
Other languages
English (en)
Spanish (es)
Inventor
Gerhard Dr Scheffler
Ilona Dr Fleischhauer
Bernhard Dr Kutscher
Jurgen Prof Engel
Stefan Prof Szelenyi
Ulrich Dr Werner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Medica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica GmbH filed Critical Asta Medica GmbH
Application granted granted Critical
Publication of ES2108066T3 publication Critical patent/ES2108066T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES92117672T 1991-10-31 1992-10-16 Nuevas ftalazinas que en posicion 1 contienen una agrupacion eter, y procedimiento para su preparacion. Expired - Lifetime ES2108066T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4135910 1991-10-31

Publications (1)

Publication Number Publication Date
ES2108066T3 true ES2108066T3 (es) 1997-12-16

Family

ID=6443832

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92117672T Expired - Lifetime ES2108066T3 (es) 1991-10-31 1992-10-16 Nuevas ftalazinas que en posicion 1 contienen una agrupacion eter, y procedimiento para su preparacion.

Country Status (20)

Country Link
US (1) US5354750A (OSRAM)
EP (1) EP0539805B1 (OSRAM)
JP (1) JPH05222002A (OSRAM)
KR (1) KR930007914A (OSRAM)
CN (1) CN1071916A (OSRAM)
AT (1) ATE157656T1 (OSRAM)
AU (1) AU660726B2 (OSRAM)
BR (1) BR9204187A (OSRAM)
CA (1) CA2081819A1 (OSRAM)
DE (2) DE59208852D1 (OSRAM)
DK (1) DK0539805T3 (OSRAM)
ES (1) ES2108066T3 (OSRAM)
FI (1) FI924934L (OSRAM)
GR (1) GR3025141T3 (OSRAM)
HU (2) HUT62866A (OSRAM)
IL (1) IL103601A0 (OSRAM)
MX (1) MX9206245A (OSRAM)
NO (1) NO924166L (OSRAM)
TW (1) TW211563B (OSRAM)
ZA (1) ZA928420B (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9226573D0 (en) * 1992-12-21 1993-02-17 Ici Plc Heterocyclic compounds
US6291425B1 (en) 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US20020028813A1 (en) * 1997-09-03 2002-03-07 Paul F. Jackson Thioalkyl compounds, methods, and compositions for inhibiting parp activity
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6514983B1 (en) 1997-09-03 2003-02-04 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6346536B1 (en) 1997-09-03 2002-02-12 Guilford Pharmaceuticals Inc. Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
US6197785B1 (en) 1997-09-03 2001-03-06 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
AU2001264595A1 (en) 2000-05-19 2001-12-03 Guilford Pharmaceuticals Inc. Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses
WO2002044157A2 (en) * 2000-12-01 2002-06-06 Iconix Pharmaceuticals, Inc. Parb inhibitors
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2484029A (en) * 1945-12-21 1949-10-11 Ciba Pharm Prod Inc Hydrazine derivatives of pyridazine compounds
US3882119A (en) * 1970-01-27 1975-05-06 Lepetit Spa Tetracyclic substituted phthalazine compounds
IL48319A0 (en) * 1974-10-26 1975-12-31 Merck Patent Gmbh Araliphatic nitrogen compounds and a process for their preparation
JPH01261386A (ja) * 1988-04-11 1989-10-18 Nisshin Flour Milling Co Ltd 新規な2―ピリジルメチルチオ誘導体及びそれを含有する抗潰瘍剤

Also Published As

Publication number Publication date
CA2081819A1 (en) 1993-05-01
FI924934A7 (fi) 1993-05-01
AU2747192A (en) 1993-05-06
HU9203431D0 (en) 1993-01-28
FI924934A0 (fi) 1992-10-30
AU660726B2 (en) 1995-07-06
DK0539805T3 (da) 1998-03-23
ATE157656T1 (de) 1997-09-15
BR9204187A (pt) 1993-05-04
HUT62866A (en) 1993-06-28
NO924166L (no) 1993-05-03
MX9206245A (es) 1993-05-01
DE4234933A1 (de) 1993-05-06
FI924934L (fi) 1993-05-01
TW211563B (OSRAM) 1993-08-21
JPH05222002A (ja) 1993-08-31
DE59208852D1 (de) 1997-10-09
US5354750A (en) 1994-10-11
NO924166D0 (no) 1992-10-29
IL103601A0 (en) 1993-03-15
EP0539805B1 (de) 1997-09-03
ZA928420B (en) 1993-05-14
HU211863A9 (en) 1995-12-28
CN1071916A (zh) 1993-05-12
KR930007914A (ko) 1993-05-20
EP0539805A1 (de) 1993-05-05
GR3025141T3 (en) 1998-02-27

Similar Documents

Publication Publication Date Title
ES2108066T3 (es) Nuevas ftalazinas que en posicion 1 contienen una agrupacion eter, y procedimiento para su preparacion.
ES2121843T3 (es) N-((1,3,5-triazin-2-il)aminocarbonil)benzosulfonamidas herbicidas.
ES2040838T3 (es) Compuestos piperazinil-heterociclicos.
GT199800038A (es) Atropisomeros de 3-aril-4(3h)-quinazolinonas.
ES2104673T3 (es) Hidroximetil(metilenciclopentil)purinas y pirimidinas.
ES2153820T3 (es) Derivados de benzimidazol, procedimiento para su preparacion y aplicaciones.
DK0469013T3 (da) Hidtil ukendte arylpyridaziner, fremstilling deraf, anvendelse deraf og lægemidler indeholdende disse
YU26691A (sh) BORNO KISELINSKI ADUKTI RENIJUM DIOKSIM I TEHNICIJUM-99 m DIOKSIM KOMPLEKSA I PRIBOR ZA MARKIRANJE SA TEHNICIJUMOM 99 m I/ILI RADIONUKLEIDOM RENIJUMA
ES8507534A1 (es) Procedimiento para la preparacion de derivados benzopiranicos
UY25242A1 (es) Inhibidores de benzotiazol de la proteína tirosina cinasa
ES8504140A1 (es) Procedimiento para la preparacion de nuevos bencimidazoles substituidos
DE69112435D1 (de) Verdampfer für anästhetische Zwecke.
TR199500826A2 (tr) Multipl ünite tablet doz formu 2.
CR7362A (es) Formulaciones farmaceuticas de derivado de platino
GT199900150A (es) 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino sustituidas.
AR224495A1 (es) Procedimiento para la preparacion de derivados de 1-fenil-7,8-dihidroxi o 7,8-dialcanoiloxi-1,3,4,5-tetrahidro-1h-3-benzazepina y sus sales
ES2150039T3 (es) Benzonitrilos como 5-ht agonistas y antagonistas.
ES2057015T3 (es) 2-alcoxi-fenoxisulfonil-ureas heterociclicas y su utilizacion como herbicidas o reguladores del crecimiento de las plantas.
ES2193055T3 (es) Cloruro de n- (2-hidroxi-3- (1-piperidinil) piridina-1-oxido-3-carboximidoilo y su uso en el tratamiento de la resistencia a la insulina.
DK0459256T3 (da) Oxazolidiononer
ES2182454T3 (es) Derivados de amida y su uso terapeutico.
DK1098870T3 (da) Nitratsalt af Cetirizin
AR025797A1 (es) Quinazolinonas
AR008244A1 (es) Compuestos heterociclicos, procedimiento para prepararlos, composiciones farmaceuticas que los comprenden, uso de dichos compuestos en la fabricacion de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos
ES2056955T3 (es) Formulacion oral de buspirona y sales de la misma.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 539805

Country of ref document: ES